Kugelmas M - Search Results

1

Immunosuppression in liver transplantation.

Everson GT, Trotter JF, Kugelmas M, Forman L. Everson GT, et al. Among authors: kugelmas m. Minerva Chir. 2003 Oct;58(5):725-40. Minerva Chir. 2003. PMID: 14603151 Review.

2

Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications.

Dunkelberg JC, Trotter JF, Wachs M, Bak T, Kugelmas M, Steinberg T, Everson GT, Kam I. Dunkelberg JC, et al. Among authors: kugelmas m. Liver Transpl. 2003 May;9(5):463-8. doi: 10.1053/jlts.2003.50079. Liver Transpl. 2003. PMID: 12740787 Free article. Clinical Trial.

3

Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus.

Trotter JF, Wachs ME, Trouillot TE, Bak T, Kugelmas M, Kam I, Everson G. Trotter JF, et al. Among authors: kugelmas m. Liver Transpl. 2001 May;7(5):401-8. doi: 10.1053/jlts.2001.23916. Liver Transpl. 2001. PMID: 11349259 Free article.

4

Right hepatic lobe donation for living donor liver transplantation: impact on donor quality of life.

Trotter JF, Talamantes M, McClure M, Wachs M, Bak T, Trouillot T, Kugelmas M, Everson GT, Kam I. Trotter JF, et al. Among authors: kugelmas m. Liver Transpl. 2001 Jun;7(6):485-93. doi: 10.1053/jlts.2001.24646. Liver Transpl. 2001. PMID: 11443574 Free article.

5

Adult-to-adult living donor liver transplantation using right-lobe grafts: results and lessons learned from a single-center experience.

Bak T, Wachs M, Trotter J, Everson G, Trouillot T, Kugelmas M, Steinberg T, Kam I. Bak T, et al. Among authors: kugelmas m. Liver Transpl. 2001 Aug;7(8):680-6. doi: 10.1053/jlts.2001.26509. Liver Transpl. 2001. PMID: 11510011 Free article.

6

Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.

Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, Wright EC, Lee WM, Lok AS, Bonkovsky HL, Morgan TR, Ghany MG, Morishima C, Snow KK, Dienstag JL; HALT-C Trial Investigators. Di Bisceglie AM, et al. N Engl J Med. 2008 Dec 4;359(23):2429-41. doi: 10.1056/NEJMoa0707615. N Engl J Med. 2008. PMID: 19052125 Free PMC article. Clinical Trial.

7

Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation.

Attwell A, Ludkowski M, Nash R, Kugelmas M. Attwell A, et al. Among authors: kugelmas m. Aliment Pharmacol Ther. 2004 Oct 15;20(8):867-73. doi: 10.1111/j.1365-2036.2004.02190.x. Aliment Pharmacol Ther. 2004. PMID: 15479358 Free article.

8

Budd-Chiari syndrome. Treatment options and the value of liver transplantation.

Kugelmas M. Kugelmas M. Hepatogastroenterology. 1998 Sep-Oct;45(23):1381-6. Hepatogastroenterology. 1998. PMID: 9840069

9

Immunosuppressive drug-induced leukoencephalopathy in patients with liver transplant.

Idilman R, De Maria N, Kugelmas M, Colantoni A, Van Thiel DH. Idilman R, et al. Among authors: kugelmas m. Eur J Gastroenterol Hepatol. 1998 May;10(5):433-6. doi: 10.1097/00042737-199805000-00015. Eur J Gastroenterol Hepatol. 1998. PMID: 9619393

10

Alcoholic liver disease. Treatment strategies for the potentially reversible stages.

Hill DB, Kugelmas M. Hill DB, et al. Among authors: kugelmas m. Postgrad Med. 1998 Apr;103(4):261-4, 267-8, 273-5. doi: 10.3810/pgm.1998.04.462. Postgrad Med. 1998. PMID: 9553600 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page